Legend Biotech appoints Ingrid Zhang as CEO; shares gain

** Shares of drugmaker Legend Biotech LEGN.O gain 2.6% to $19.02 in premarket trading

** The company appoints longtime Novartis NOVN.S executive Ingrid Zhang as CEO

** LEGN also says Alan Bash, who had been serving as interim CEO, will return to his role as president of the Carvykti business

** In August, the company beat Q2 earnings estimates

** Eleven of 16 brokerages rate the stock "buy" or higher, five "hold"; their median PT is $56 — LSEG-compiled data

** Up to last day's close, shares are down 14.8% YTD